OUR FRAGMENT PRODUCTS

Please visit zenobiafragments.com to learn more about our products to support your screening needs. Our products are used in our internal CNS discovery research programs and have yielded hits for a diverse array of targets around the world. We also offer a collection of support services to compliment our products.

FRAGMENT LIBRARY

Full collection of 967 highly core diverse fragments that meet our internal Guideline of Two

Learn More

FRADDITIVES FOR CRYSTALLIZATION

Unique fragment-based reagents for protein solubilization and crystallization

Learn More

SERVICES

Screening and structural biology services to compliment your fragment library purchase

Learn More

ALL ABOUT US

Our Background

Zenobia Therapeutics was founded in 2008 with a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery. In 2014, Zenobia added a products division, Zenobia Fragments that supplies products and services to support fragment-based lead discovery.

Learn More about Zenobia Fragments

ZENOBIA THERAPEUTICS

A Leader in FBLD and CNS disease

Home Homepage_about

Home Product